Ranibizumab for neovascular age-related macular degeneration.

Rosenfeld, P.; M. Brown, David; Heier, J.; Boyer, D.; Kaiser, P.; Chung, C.; Kim, R.

doi:10.1056/NEJMOA054481

Public

Ranibizumab for Neovascular Age-Related Macular Degeneration

Shared by NobleBlocks on Oct 4, 2006 • 12:00 AM UTC

Authors:

Philip J. Rosenfeld

David M. Brown

Jeffrey S. Heier

Abstract

BACKGROUND: Ranibizumab--a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A--has been evaluated for the treatment of neovascular age-related macular degeneration. METHODS: In this multicenter, 2-year, double-blind, sham-control...

Subject

Macular degeneration

Ranibizumab

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!